Patent US4960416A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4960416A Expired / Lapsed US ⏱️ 0.0 years remaining

Dosage form with improved delivery capability

Assignee: Alza Corp
•
Filing: 1989-07-10
•
Granted: 1990-10-02
•
Expires: 2009-07-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A dosage form is disclosed comprising a wall surrounding a compartment housing a first layer comprising a drug formulation, a middle layer comprising a hydrophobic composition, and a third layer comprising a hydrophilic composition.

Inventors

  • 👤 Sally I. Stephens
  • 👤 Patrick S. L. Wong

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 01:50
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0002; A61K9/0004

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 199 words
A dosage form for delivering a beneficial agent to a fluid environment of use, comprising: (a) a wall comprising in at least a part a semipermeable composition permeable to the passage of an exterior aqueous fluid and substantially impermeable to the passage of a beneficial agent, which wall surrounds and forms: (b) a compartment; (c) a first layer comprising a beneficial agent in the compartment, which layer forms in situ a dispensable aqueous formulation with fluid that enters the compartment; (d) a third layer comprising means for expanding and occupying space in the presence of fluid in the compartment; (e) a second layer interposed between the first and third layer in the compartment, said second layer a separate and distinct layer comprising a different composition than the first and third layers, which second layer comprises a non-expandable hydrophobic composition that is a means for substantially preventing the migration of the beneficial agent from the first layer comprising the dispensable aqueous formulation into the third layer; and, (f) means in the wall connecting the exterior of the dosage form with the compartment, said means for connecting the exterior of the dosage form with the interior compartment comprising a microporous member.
Claim 2
Dependent Claim 199 words
A dosage form for delivering a beneficial agent to a fluid environment of use, comprising: (a) a wall comprising in at least a part a semipermeable composition permeable to the passage of an exterior aqueous fluid and substantially impermeable to the passage of a beneficial agent, which wall surrounds and forms: (b) a compartment; (c) a first layer comprising a beneficial agent in the compartment, which layer forms in situ a dispensable aqueous formulation with fluid that enters the compartment; (d) a third layer comprising means for expanding and occupying space in the presence of fluid in the compartment; (e) a second layer interposed between the first and third layer in the compartment, said second layer a separate and distinct layer comprising a different composition than the first and third layers, which second layer comprises a non-expandable hydrophobic composition that is a means for substantially preventing the migration of the beneficial agent from the first layer comprising the dispensable aqueous formulation into the third layer; and, (f) means in the wall connecting the exterior of the dosage form with the compartment, said means for connecting the exterior of the dosage form with the interior compartment comprising a microporous member.
Claim 3
Dependent Claim 43 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein when the dosage form is in operation the second layer adapts a shaped surface corresponding to the shaped surface of an expanding third layer.
Claim 4
Dependent Claim 54 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the second layer comprises a surface in contact with a surface of the third layer, which surfaces maintain their physical and chemical integrity essentially free from precipitation during the beneficial agent delivery period of time.
Claim 5
Dependent Claim 32 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the beneficial agent is poorly soluble in the means comprising the second layer.
Claim 6
Dependent Claim 35 words
The dosage form for delivering the beneficial agent to an aqueous fluid environment of use according to claim 1, wherein the second layer is independent and moves concomitantly with a moving first and third layer.
Claim 7
Dependent Claim 28 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the second layer means comprises a hydrophobic polymeric composition.
Claim 8
Dependent Claim 35 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the beneficial agent is poorly soluble in the second layer means comprising a hydrophobic polymeric composition.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-10-01 1994-04-02 1994-10-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-10-01 1998-04-02 1998-10-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-10-01 2002-04-02 2002-10-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag